Andlauer Healthcare Group Inc.
AND.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.11% | 0.17% | -1.81% | -5.02% | -3.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.11% | 0.17% | -1.81% | -5.02% | -3.66% |
| Cost of Revenue | -1.49% | -0.09% | -1.39% | -4.00% | -1.97% |
| Gross Profit | -0.36% | 0.69% | -2.65% | -7.00% | -6.89% |
| SG&A Expenses | 1.99% | 0.82% | 2.40% | -0.33% | 2.93% |
| Depreciation & Amortization | 2.55% | 4.09% | 4.87% | 4.05% | 1.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.67% | 0.51% | -0.28% | -2.71% | -1.06% |
| Operating Income | -3.69% | -1.76% | -10.03% | -16.65% | -16.31% |
| Income Before Tax | -4.15% | -2.74% | -9.54% | -16.38% | -15.82% |
| Income Tax Expenses | -4.50% | -0.31% | -7.58% | -13.93% | -14.21% |
| Earnings from Continuing Operations | -4.02% | -3.62% | -10.25% | -17.26% | -16.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.02% | -3.62% | -10.25% | -17.26% | -16.40% |
| EBIT | -3.69% | -1.76% | -10.03% | -16.65% | -16.31% |
| EBITDA | -2.95% | -18.28% | -22.24% | -19.39% | -12.85% |
| EPS Basic | -0.43% | -0.95% | -9.18% | -16.72% | -16.21% |
| Normalized Basic EPS | -0.57% | -0.06% | -8.48% | -15.84% | -15.84% |
| EPS Diluted | -0.19% | -1.43% | -9.45% | -16.86% | -15.96% |
| Normalized Diluted EPS | -0.11% | 0.07% | -8.39% | -15.80% | -15.77% |
| Average Basic Shares Outstanding | -3.49% | -2.66% | -1.14% | -0.61% | -0.17% |
| Average Diluted Shares Outstanding | -3.90% | -2.78% | -1.26% | -0.68% | -0.27% |
| Dividend Per Share | 21.67% | 23.93% | 25.27% | 26.35% | 26.19% |
| Payout Ratio | 0.21% | 0.24% | 0.37% | 0.52% | 0.51% |
